Pharma Mar SA (PHMMF)
94.60
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Pharma Mar Cash and Short Term Investments (Annual) : 196.40M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 196.40M |
| December 31, 2024 | 160.01M |
| December 31, 2023 | 179.57M |
| December 31, 2022 | 194.69M |
| December 31, 2021 | 229.58M |
| December 31, 2020 | 239.22M |
| December 31, 2019 | 23.45M |
| December 31, 2018 | 30.72M |
| December 31, 2017 | 38.14M |
| December 31, 2016 | 15.07M |
| December 31, 2015 | 8.287M |
| December 31, 2014 | 42.95M |
| December 31, 2013 | 39.63M |
| December 31, 2012 | 43.49M |
| December 31, 2011 | 64.03M |
| Date | Value |
|---|---|
| December 31, 2010 | 89.32M |
| December 31, 2009 | 90.81M |
| December 31, 2008 | 86.66M |
| December 31, 2007 | 143.07M |
| December 31, 2006 | 132.48M |
| December 31, 2005 | 163.68M |
| December 31, 2004 | 162.83M |
| December 31, 2003 | 160.67M |
| December 31, 2002 | 146.61M |
| December 31, 2001 | 70.07M |
| December 31, 2000 | 113.33M |
| December 31, 1999 | 9.850M |
| December 31, 1998 | 10.97M |
| December 31, 1997 | 11.76M |
| December 31, 1996 | 9.812M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Oryzon Genomics SA | 33.32M |
| Grifols SA | 968.92M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alkermes Plc | 1.319B |
| Alnylam Pharmaceuticals, Inc. | 2.908B |